Vivos Therapeutics, Inc. Warrants and Rights Outstanding
Vivos Therapeutics, Inc. (VVOS) had Warrants and Rights Outstanding of $0 as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2025-11-19
- 2025-09-30: Warrants and Rights Outstanding $0.00.
- 2025-06-30: Warrants and Rights Outstanding $0.00.
- 2025-03-31: Warrants and Rights Outstanding $0.00.
- 2024-12-31: Warrants and Rights Outstanding $0.00.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-19 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-19 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $19.20M 10-K/A · filed 2024-07-30 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-16 |
| 2023-03-31 | $0.00 10-Q · filed 2023-06-08 |
| 2022-12-31 | $0.00 10-K/A · filed 2024-07-30 |
| 2022-09-30 | $0.00 10-Q · filed 2022-12-20 |
| 2022-03-31 | $0.00 10-Q/A · filed 2022-11-25 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |